Basic Information
Basic information for OLMALINC-229-52aa-1
Peptide Name OLMALINC-229-52aa-1
Genome Position chr10:100381294-100381448,100388037-100388037[+]
Species Human
Peptide Sequence MHVTFGAEDPGQEDSFGRPVPCCRPHSVRRSTYDLRSSDQPAQGTSCQFQIG
Peptide Length 52
Unique No (OLMALINC-201-52aa,OLMALINC-203-52aa,OLMALINC-205-52aa,OLMALINC-209-52aa,OLMALINC-210-52aa,OLMALINC-215-52aa,OLMALINC-217-52aa,OLMALINC-219-52aa,OLMALINC-220-52aa,OLMALINC-224-52aa,OLMALINC-227-52aa)
Grand Average of Hydropathicity -0.8327
Relative Molecular Mass 6659.17
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000235823;OLMALINC
Transcript ID/Name ENST00000666154;OLMALINC-229
Transcript Length 1070
Coding Ability 0.571
DNA Sequence Corresponding to Peptide ATGCATGTGACATTTGGTGCTGAAGACCCAGGACAGGAGGACTCCTTTGGGAGACCAGTGCCCTGTTGTCGCCCTCACTCCGTGAGGAGATCCACCTATGATCTCAGGTCCTCAGACCAACCAGCCCAAGGAACATCTTGCCAATTTCAAATCGGA
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :